REVB: Revelation Biosciences, Inc. Stock

by  •  • Comments Off on REVB: Revelation Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.56
Enterprise Value ($M) -8.43
Book Value ($M) 6.65
Book Value / Share 4.07
Price / Book 0.54
NCAV ($M) 6.58
NCAV / Share 4.03
Price / NCAV 0.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.02
Return on Assets (ROA) -0.01
Return on Equity (ROE) -0.01

Liquidity (mrq)
Quick Ratio 2.18
Current Ratio 2.18

Balance Sheet (mrq) ($M)
Current Assets 12.15
Assets 12.21
Liabilities 5.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.66
Net Income -0.12

Cash Flow Statement (mra) ($M)
Cash From Operations -7.29
Cash from Investing 0.00
Cash from Financing 14.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Lind Global Fund II LP 2.90 0.00
01-03 13G Sabby Management, Llc 6.40

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-22 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 14,563 3,107 468.72
2024-04-25 2,260 899 251.39
2024-04-24 14,839 6,164 240.74
2024-04-23 9,067 6,331 143.22

(click for more detail)

Similar Companies
QLGN – Qualigen Therapeutics, Inc. QLI – Qilian International Holding Group Limited
RENB – Renovaro Inc. RGC – Regencell Bioscience Holdings Limited
RGLS – Regulus Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io